Symyx Acquisition Drives 46 Percent Q3 Revenue Boost for Accelrys | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys today reported a 46 percent increase in revenues for the three-month period ended Sept. 30, the first full quarter to include revenues from its acquisition of Symyx Technologies in July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.